[1]Hornykiewicz O. Dopamine (3-hydroxytyramine) and brain function[J]. Pharmacol Rev,1966, 18(2):925-964.
[2]Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality[J]. Neurology, 1967,17:427-442.
[3]Qin JW, Li HZh, Liang PP, et al. MRI combined with the volume of the hippocampus and the entorhinal cortex to indentify Alzheimer’s disease and mild cognitive impairment[J]. Journal of Medical Imaging, 215, 25(9):1515-1519. (in Chinese)
秦嘉玮, 李慧卓, 梁佩鹏, 等. MRI联合海马、内嗅皮层体积鉴别阿尔茨海默病和轻度认知障碍[J]. 医学影像学杂志,2015,25(9):1515-1519.
[4]Femminella GD, Ninan S, Atkinson R, et al. Does microglial activation influence hippocampal volume and neuronal function in Alzheimer’s disease and Parkinson’s disease dementia [J] ? J Alzheimer’s Dis,2016,51(4):1275-1289.
[5]Chung SJ, Shin JH, Chokh, et al. Subcortical shape analysis of progressive mild cognitive impairment in Parkinson’s disease[J]. Mov Disord,2017,32 (10):1447-1456.
[6]Zhang WZh, Lu FF, Xue Sh, et al. Parkinson’s 3D reconstruction of subthalamic nucleus[J]. Electronic of Transformation Medicine, 2016, 3(3);5-8. (in Chinese)
张伟忠, 卢凤飞, 薛杉, 等. 帕金森患者丘脑底核三维重建[J]. 转化医学电子杂志,2016,3(3):5-8.
[7]Breen DP, Nombela C, Vuono R, et al. Hypothalamic volume loss is associated with reduced melatonin output in Parkinson’s Disease[J]. Mov Disord,2016, 31(7):1062-1066.[8]Choi S M, Kim B C, Chang J, et al. Comparison of the brain volume in essential tremor and Parkinson’s disease tremor using an automated segmentation method[J]. Eur Neurol, 2015,73(5-6):303-309.
[9]Liu F, Fan GG, Wang C, et al. Measurements of basal ganglia volume in patients with Parkinson’s disease by 3.0 TMR. magnetic sensitive weighted imaging[J]. Central Neuroimaging, 2011, 27(3): 483-486. (in Chinese)
刘芳, 范国光, 王慈, 等. 3.0T MR磁敏感加权成像测量帕金森病患者基底节区体积[J]. 中枢神经影像学, 2011,27(3):483-486.
[10]O’Nei ll J, Schuff N, Marks WJ, et al. Quantitative 1H magnetic resonance spectroscopy and MRI of Parkinson’ s disease [J]. Mov Dis, 2002,17(5):917-927.
[11]Almeida OP, Burton EJ, McKeith L, et al. MRI study of caudate nucleus volume in Parkinson’ s disease with and without dementia with Lewy bodies and Alzheimer’ s disease [J]. Dement Geriatr Cong Disord,2003,16(2):57-63.
[12]Crutcher MD, DeLong MR. Single cell studies of the pritamen.Ⅰ. Functional organization [J]. Exp Brain Res,1984,53(2):233-243.
[13]Foo H, Mak E, Yong TT, et al. Progression of subcortical atrophy in mild Parkinson’s disease and its impact on cognition[J]. Eur J Neurol,2017,24(2):341-348.
[14]Lee SH, Kim SS, Tae WS, et al. Regional volume analysis of the Parkinson disease brain in early disease stage: gray matter, white matter, striatum, and thalamus [J]. J Neuroradiol,2011,32(4):682-687.
[15]Lewis MM, Du G, Lee EY, et al. The pattern of gray matter atrophy in Parkinson’s disease differs in cortical and subcortical Regions[J]. J Neurol,2016;263(1):68-75.
[16]Zhang Y, Zhang J, Xu J, et al. Cortical gyrification reductions and subcortical atrophy in Parkinson’s disease[j].Mov Disord, 2014,29(1):122-126.
[17]Pitcher T L, Melzer T R, Macaskill M R, et al. Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study [J]. Transl Neurodegener,2012,1(1):17.[18]van Mierlo TJ, Chung C, Foncke EM, et al. Depressive symptoms in Parkinson’s disease are related to decreased hippocampus and amygdala volume[J]. Mov Disord, 2015,30(2):245-252.
[19]Camicioli R, Moore M.M, Kinney A, et al. Parkinson’s disease is associated with hippocampal atrophy [J]. Mov Disord,2003,18(7):784-790.
[20]Junque C, Ramirez-Ruiz B, Tolosa E, et al. Amygdalar and hippocampal MRI volumetric reductions in Parkinson’s disease with dementia [J]. Mov Disord, 2005,20(5):540-544.
[21]Bouchard TP, Malykhin N, Martin WR, et al. Age and dementia-associated atrophy predominates in the hippocampal head and amygdala in Parkinson’s disease [J]. Neurobiol Aging, 2008,29(7):1027-1039.
[22]Vriend C, Boedhoe P S, Rutten S, et al. A smaller amygdala is associated with anxiety in Parkinson’s disease: a combined FreeSurfer—VBM study[J]. J Neurol Neurosurg Psychiatry, 2016, 87(5):493-500.
|